ORIGINAL ARTICLE |
|
Year : 2012 | Volume
: 49
| Issue : 3 | Page : 283-286 |
Accuracy of imaging-guided biopsy in diagnosis of malignancy versus infection
FB Cakir1, DB Genc2, C Canpolat3, E Aribal4, SG Berrak5
1 Department of Pediatrics,Division of Pediatric Hematology-Oncology,Bezmialem Vakif University School of Medicine, Istanbul, Turkey 2 Anadolu Medical Center, Pediatric Hematology-Oncology, Istanbul, Turkey 3 Acibadem University School of Medicine, Pediatric Hematology-Oncology, Istanbul, Turkey 4 Marmara University School of Medicine, Interventional Radiology, Istanbul, Turkey 5 The Children's Hospital at Monmouth Medical Center, Department of Pediatrics, Long Branch, NJ 07740, USA
Correspondence Address:
S G Berrak The Children's Hospital at Monmouth Medical Center, Department of Pediatrics, Long Branch, NJ 07740 USA
 Source of Support: None, Conflict of Interest: None  | Check |
DOI: 10.4103/0019-509X.104488
Aims: Imaging-guided biopsies obtain samples for pathologic testing in addition to therapeutic interventions in patients with cancer. Our aim was to determine the diagnostic accuracy of percutaneous biopsies of pediatric solid tumors and infectious complications of cancer treatment. Materials and Methods: This study was performed by gathering pediatric oncology patients between 1998 and 2008. A total of 41 percutaneous biopsies were performed in order to establish a diagnosis for a suspected malignancy or an infectious complication of cancer treatment. Results and Conclusions: An accurate diagnosis was achieved in 21 of 26 (87.6%) percutaneous biopsies for suspected malignancy cases or recurrence. The remaining 15 percutaneous biopsies were done for the diagnosis of infectious complications of cancer treatment with an accurate diagnosis of 60%. Imaging-guided percutaneous biopsy technique is highly accurate and safe, particularly in diagnosis of a suspected tumor.
[FULL TEXT] [PDF]*
|